Conventional and nanotechniques for DNA methylation profiling

Journal of Molecular Diagnostics

Volumn 15, Issue 1, 2013, Pages 17-26

  Shanmuganathan, Rajasree ^a   Basheer, Nazeema B ^b   Amirthalingam, Laxmi ^b   Muthukumar, Harshiny ^b   Kaliaperumal, Rajendran ^b   Shanmugam, Kumaran ^b  

^a CoRx Lifesciences and Pharmaceutical Pvt Ltd ^*  (India)

^b PERIYAR MANIAMMAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; COMPLEMENTARY DNA; DNA; GENOMIC DNA; NANOWIRE; OLIGONUCLEOTIDE; QUANTUM DOT;

ALLELE; ANALYTIC METHOD; ATOMIC FORCE MICROSCOPY; ATOMIC FORCE SPECTROSCOPY; BISULFITE SEQUENCING; BLOTTING; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUOROMETRY; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; NANOTECHNOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SINGLE MOLECULE REAL TIME DETECTION; SPECTROSCOPY;

EID: 84875457313     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.06.007     Document Type: Review

References (102)

1. Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093
2. Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 2004, 4:988-993
3. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96:8681-8686
4. Hughes LA, Khalid-de Bakker CA, Smits KM, van den Brandt PA, Jonkers D, Ahuja N, Herman JG, Weijenberg MP, van Engeland M: The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta 2012, 1825:77-85
5. Samowitz WS: The CpG island methylator phenotype in colorectal cancer. J Mol Diagn 2007, 9:281-283
6. Marsit CJ, Houseman EA, Christensen BC, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR, Kelsey KT: Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 2006, 66:10621-10629
7. Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, Gazdar AF, Fujisawa T: Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer 2006, 106: 2200-2207
8. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, Issa JP: DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002, 94:755-761
9. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, Baylin SB, Ahuja N, Viale A, Massague J, Norton L, Vahdat LT, Moynahan ME, Chan TA: Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011, 3:75ra25
10. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 2003, 3:253-266
11. van Engeland M, Derks S, Smits KM, Meijer GA, Herman JG: Colorectal cancer epigenetics: complex simplicity. J Clin Oncol 2011, 29:1382-1391
12. Esteller M: Epigenetics in cancer. N Engl J Med 2008, 358: 1148-1159
13. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21
14. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capella G, Ribas M, Peinado MA: Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 2006, 66: 8462-8468
15. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature 1998, 395:89-93
16. Ogino S, Nosho K, Kirkner GJ, Takako Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS: A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008, 100:1734-1738
17. Estecio MRH, Gharibyan V, Shen L, Ibrahim AEK, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang THM, Tajara EH, Issa JPJ: LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007, 2:e399
18. Falette NS, Fuqua SAW, Chamness GC, Cheah MS, Greene GL, McGuire WL: Estrogen receptor gene methylation in human breast tumors. Cancer Res 1990, 50:3974-3978
19. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE: Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 1994, 54:2552-2555
20. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-4530
21. Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JPJ, Davidson NE: Methylation of estrogen and progesterone receptor gene 50 CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res 1996, 2:805-810
22. Huynh H, Alpert L, Pollak M: Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes. Cancer Res 1996, 56:4865-4870
23. Hakkarainen M, Wahlfors J, Myohanen S, Hiltunen MO, Eskelinen M, Johansson R, Janne J: Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing. Int J Cancer (Pred Oncol) 1996, 69:471-474
24. Shinozaki M, Hoon DSB, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 2005, 11:2156-2162
25. Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S: Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 2005, 11:1380-1385
26. Sepulveda AR, Jones D, Ogino S, Samowitz W, Gulley ML, Edwards R, Levenson V, Pratt VM, Yang B, Nafa K, Yan L, Vitazka P: CpG methylation analysis: current status of clinical assays and potential applications in molecular diagnostics. J Mol Diagn 2009, 11:266-278
27. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB: Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 2005, 97:273-282
28. Curtin K, Slattery ML, Samowitz WS: CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int 2011, 2011:1-8
29. Issa JP, Kantarjian HM: Targeting DNA methylation. Clin Cancer Res 2009, 15:3938-3946
30. Ogino S, Chan AT, Fuchs CS, Giovannucci E: Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011, 60:397-411
31. Murcia GD, Lang MCE, Freund AM, Fuchs RPP, Daune MP, Sage E, Leng M: Electron microscopic visualization of N-acetoxy-N-2-acetylaminofluorene binding sites in ColE1 DNA by means of specific antibodies. Proc Natl Acad Sci U S A 1979, 76:6076-6080
32. Sano H, Royer HD, Sager R: Identification of 5-methylcytosine in DNA fragments immobilized on nitrocellulose paper. Proc Natl Acad Sci U S A 1980, 77:3581-3585
33. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci U S A 1984, 81:1991-1995
34. Saluz H, Jost JP: A simple high-resolution procedure to study DNA methylation and in vivo DNA-protein interactions on a single-copy gene level in higher eukaryotes. Proc Natl Acad Sci U S A 1989, 86:2602-2606
35. Pfeifer GP, Steigerwald SD, Mueller PR, Wold B, Riggs AD: Genomic sequencing and methylation analysis by ligation mediated PCR. Science 1989, 246:810-813
36. Mueller PR, Wold B: In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 1989, 246:780-786
37. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992, 89:1827-1831
38. Shapiro R, Braverman B, Louis JB, Servis RE: Nucleic acid reactivity and conformation, II: reaction of cytosine and uracil with sodium bisulfite. J Biol Chem 1973, 248:4060-4064
39. Wang RYH, Gehrke CW, Ehrlich M: Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucl Acids Res 1980, 8:4777-4790
40. Smith ZD, Gu H, Bock C, Gnirke A, Meissner A: High-throughput bisulfite sequencing in mammalian genomes. Methods 2009, 48: 226-232
41. Tanaka K, Okamoto A: Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett 2007, 17:1912-1915
42. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gra S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Backdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJP, Durbin R, Tavare S, Beck S: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nature Biotechnol 2008, 26:779-785
43. Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M, Jacobsen SE: Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008, 452:215-219
44. Lister R, O'Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, Ecker JR: Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 2008, 133:523-536
45. Beck S, Rakyan VK: The methylome: approaches for global DNA methylation profiling. Trends Genet 2008, 24:231-237
46. Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R: Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucl Acids Res 2005, 33:5868-5877
47. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454: 766-771
48. Jeddeloh JA, Greally JM, Rando OJ: Reduced-representation methylation mapping. Genome Biol 2008, 9:231.1-231.4
49. Zhang X, Yazaki J, Sundaresan A, Cokus S, Chan SWL, Chen H, Henderson IR, Shinn P, Pellegrini M, Jacobsen SE, Ecker JR: Genome-wide high-resolution mapping and functional analysis of DNA methylation in Arabidopsis. Cell 2006, 126:1-13
50. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005, 37:853-862
51. Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M: Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006, 66:6118-6128
52. Schilling E, Rehli M: Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 2007, 90:314-323
53. Fraga MF, Esteller M: DNA methylation: a profile of methods and applications. Biotechniques 2002, 33:632-649
54. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 2003, 3:253-266
55. Smith AE, Ford KG: Specific targeting of cytosine methylation to DNA sequences in vivo. Nucl Acids Res 2007, 35:740-754
56. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996, 93:9821-9826
57. House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV: Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behaviour. J Gastrointest Surg 2003, 7:1004-1014
58. Derks S, Lentjes MHFM, Hellebrekers DMEI, Bruine APD, Herman JG, Engeland MV: Methylation-specific PCR unraveled. Cell Oncol 2004, 26:291-299
59. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW: MethyLight: a high-throughput assay to measure DNA methylation. Nucl Acids Res 2000, 28. e32i-e32viii
60. Lo YMD, Wong IHN, Zhang J, Tein MSC, Ng MHL, Hjelm NM: Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res 1999, 59:3899-3903
61. Rand K, Qu W, Ho T, Clark SJ, Molly P: Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives. Methods 2002, 27: 114-120
62. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60: 5954-5958
63. Yang B, Guo M, Herman JG, Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003, 163:1101-1107
64. Harrison J, Stirzaker C, Clark SJ: Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. Anal Biochem 1998, 264: 129-132
65. Rein T, Natale DA, Gartner U, Niggemann M, DePamphilis ML, Zorbas H: Absence of an unusual "densely methylated island" at the hamster dhfr ori-b. J Biol Chem 1997, 272:10021-10029
66. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S: Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004, 64:4442-4452
67. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG: In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A 1999, 96:12754-12759
68. Zhang F, Wang L, Wu PP, Yan ZW, Zheng L, Yu YY, Jiang XC: In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma. Chin J Dig Dis 2004, 5:149-155
69. Nan X, Meehan RR, Bird A: Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucl Acids Res 1993, 21:4886-4892
70. Pfister S, Schlaeger C, Mendrzyk F, Wittmann A, Benner A, Kulozik A, Scheurlen W, Radlwimmer B, Lichter P: Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 2007, 35:e51
71. Gitan RS, Shi H, Chen CM, Yan PS, Huang THM: Methylationspecific oligonucleotide microarray: a new potential for highthroughput methylation analysis. Genome Res 2002, 12:158-164
72. Luo J, Zheng W, Wang Y, Wu Z, Bai Y, Lu Z: Detection method for methylation density on microarray using methyl-CpG-binding domain protein. Anal Biochem 2009, 387:143-149
73. Hsieh CL: Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994, 14:5487-5494
74. BachmanKE, Herman JG, Corn PG, MerloA, Costello JF, CaveneeWK, Baylin SB, Graff JR: Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res 1999, 59:798-802
75. Cameron EE, Baylin SB, Herman JG: p15INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 1999, 94:2445-2451
76. Dodge JE, List AF, Futscher BW: Selective variegated methylation of the p15 CpG island in acute myeloid leukemia. Int J Cancer 1998, 78: 561-567
77. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB: Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res 1997, 57:1030-1034
78. Gonzalgo ML, Liang G, Spruck CH 3rd, Zingg JM, Rideout WM 3rd, Jones PA: Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 1997, 57:594-599
79. Humeny A, Beck C, Becker CM, Jeltschb A: Detection and analysis of enzymatic DNA methylation of oligonucleotide substrates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Biochem 2003, 313:160-166
80. Stanssens P, Zabeau M, Meersseman G, Remes G, Gansemans Y, Storm N, Hartmer R, Honisch C, Rodi CP, Bocker S, Boom DVD: High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 2004, 14:126-133
81. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, Boom DVD: Quantitative highthroughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 2005, 102:15785-15790
82. Pal S, Alocilja EC, Downes FP: Nanowire labeled direct-charge transfer biosensor for detecting Bacillus species. Biosens Bioelectron 2007, 22:2329-2336
83. Patolsky F, Timko BP, Zheng G, Lieber CM: Nanowire-based nanoelectronic devices in the life sciences. MRS Bull 2007, 32:142-149
84. Hahm J, Lieber CM: Direct ultrasensitive electrical detection of DNA and DNA sequence variations using nanowire nanosensors. Nano Lett 2004, 4:51-54
85. Maki WC, Mishra NN, Cameron EG, Filanoski B, Rastog SK, Maki GK: Nanowire-transistor based ultra-sensitive DNA methylation detection. Biosens Bioelectron 2008, 23:780-787
86. Shanmugam K, Yoshinobu T, Moon W, Iwasaki H: Positive patterning of ferritin, and fibronectin molecules on silicon by atomic force microscopic anodic oxidation technique. J Nanosci Nanotech 2011, 11:3808-3813
87. Zhang X, Guo Q, Cui D: Recent advances in nanotechnology applied to biosensors. Sensors 2009, 9:1033-1053
88. Bailey VJ, Easwaran H, Zhang Y, Griffiths E, Belinsky SA, Herman JG, Baylin SB, Carraway HE, Wang TH: Ms-qFRET: a quantum dot-based method for analysis of DNA methylation. Genome Res 2009, 19:1455-1461
89. Bailey VJ, Keeley BP, Razavi CR, Griffiths E, Carraway HE, Wang TH: DNA methylation detection using MS-qFRET, a quantum dot-based nanoassay. Methods 2010, 52:237-241
90. Zhang CY, Yeh HC, Kuroki MT, Wang TH: Single-quantum-dotbased DNA nanosensor. Nat Mater 2005, 4:826-831
91. Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA, Korlach J, Turner SW: Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods 2010, 7:461-465
92. Tanaka K, Tainaka K, Kamei T, Okamoto A: Direct labeling of 5-methylcytosine and its applications. J Am Chem Soc 2007, 129: 5612-5620
93. Tanaka K, Tainaka K, Umemoto T, Nomura A, Okamoto A: An osmium-DNA interstrand complex: application to facile DNA methylation analysis. J Am Chem Soc 2007, 129:14511-14517
94. Bareyt S, Carell T: Selective detection of 5-methylcytosine sites in DNA. Angew Chem Int Ed 2008, 4:181-184
95. Kato D, Sekioka N, Ueda A, Kurita R, Hirono S, Suzuki K, Niwa O: A nanocarbon film electrode as a platform for exploring DNA methylation. J Am Chem Soc 2008, 130:3716-3717
96. Kato D, Goto K, Fujii S, Takatsu A, Hirono S, Niwa O: Electrochemical DNA methylation detection for enzymatically digested CpG oligonucleotides. Anal Chem 2011, 83:7595-7599
97. Ivandini TA, Honda K, Rao TN, Fujishima A, Einaga Y: Simultaneous detection of purine and pyrimidine at highly boron-doped diamond electrodes by using liquid chromatography. Talanta 2007, 71:648-655
98. Manoharan SB, Vijayasarathy M, Pazhanichamy K, NazeemaBanu B, Anandagopu P, Rajendran K, Kumaran S: Intermolecular force between monoamine oxidase B and Pseudarthria viscida (L.) using atomic force spectroscopy. J Exp Nanosci 2012. http://dx.doi.org/ 10.1080/17458080.2011.577101
99. Zhu R, Howorka S, Pröll J, Kienberger F, Preiner J, Hesse J, Ebner A, Pastushenko VP, Gruber HJ, Hinterdorfer P: Nanomechanical recognition measurements of individual DNA molecules reveal epigenetic methylation patterns. Nat Nanotechnol 2010, 5:788-791
100. Clausen-Schaumann H, Seitz M, Krautbauer R, Gaub HE: Force spectroscopy with single bio-molecules. Curr Opin Chem Biol 2000, 4:524-530
101. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994, 265:1596-1599
102. Fisher TE, Marszalek PE, Fernandez JM: Stretching single molecules into novel conformations using the atomic force microscope. Nat Struct Biol 2000, 7:719-724